ClinicalTrials.Veeva

Menu

Microcirculation During Haemodialysis

M

Medical Centre Leeuwarden

Status

Completed

Conditions

Complication of Hemodialysis

Study type

Observational

Funder types

Other

Identifiers

NCT01396980
TPO 776

Details and patient eligibility

About

  • SDF is validated by measuring changes in microcirculation in sepsis patients with MOF (Boerma studies).
  • SDF is validated by measuring changes in microcirculation in stable chronic hemodialysis patients (NDT 2009 Bemelmans).
  • Ultrafiltration in stable chronic hemodialysis leads to a decrease in sublingual microcirculatory flow (NDT 2009 Bemelmans).
  • Trendelenburg position improves the sublingual microcirculatory flow at the end of hemodialysis treatment (NDT 2009 Bemelmans).
  • Hemodialysis with ultrafiltration leads to a significant reduction of myocardial perfusion and cardiac output (NDT 2009 Dasselaar)
  • Cardiac output measurement during dialysis is not practical.
  • BVM is a validated method for hypotension due to ultrafiltration to prevent the amount of ultrafiltration online change based on the measured haemoconcentration (ref Dasselaar et al NDT 2005).
  • BCM is a validated measurement to the dry weight in hemodialysis patients measured by a bioimpedance technique (NDT Passauer et al 2009).

Full description

The search for an optimal method of ultrafiltration with minimal hypoperfusion of vital organs.

  • Stabile hemodialysis patients with dialysis dependancy for more than 3 months, with adequate access

  • Study duration 3 weeks

  • Number of hemodialysis treatment for purposes of study: 3

  • Timing hemodialysis treatments for Study session Monday or Tuesday after the weekend (randomized design in the sessions)

    • session a: 5 hours total duration: 4 hours HD without UF followed by 1 hour GUF
    • Session b: 4 hours total duration: 4 hours HD with UF
    • session c: 4 hours total duration: 4 hours HD with UF and BVM
  • UF is determined by actual target weight.

  • Measurements during sessions:

    • In each session in advance: blood pressure, pulse, weight, BCM, laboratory tests (Hb, Hct, Na, K, urea, creatinine, calcium, albumin, phosphate, nt-proBNP, troponin T, CRP)
    • During each session at t = 0, t = 1 hour, t =2 hours and t = 4 hours: SDF, blood pressure, pulse, UF at that time, UF rate at that time
    • End each session: blood pressure, pulse, weight, BCM, laboratory tests (Hb, Hct, Na, K, urea, creatinine, calcium, albumin, phosphate, nt-proBNP, troponin T, CRP)

Enrollment

8 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • dialysis patient
  • age > 18
  • informed consent

Exclusion criteria

  • no adequate access
  • instable hemodynamics

Trial design

8 participants in 1 patient group

dialysis patients
Description:
dialysis patients, stabil, dialysis dependancy for more than 3 months, with adequate access

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems